| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 03/26/2009 | US20090080074 Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device |
| 03/26/2009 | CA2700443A1 Certain substituted amides, method of making, and method of use thereof |
| 03/25/2009 | EP2039688A1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 03/25/2009 | EP2038260A1 Stereoselective synthesis of (s)-1-methyl-3-phenylpiperazine |
| 03/25/2009 | EP2038257A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer |
| 03/25/2009 | CN101395106A Dibenzoanthracene compound and organic light emitting device having the same |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/24/2009 | US7507823 Water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream including a mixture including aripiprazole and a solvent; mixing results in the substantially simultaneous dispersion and extraction of the aripiprazole from the mixture by the supercritical fluid |
| 03/24/2009 | US7507742 Spirocyclic derivatives |
| 03/24/2009 | CA2345896C A method of modulating ion channel functional activity |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009005646A3 Substituted piperazines as cb1 antagonists |
| 03/19/2009 | US20090076273 such as 2-(4-{4-[N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]-butyl}phenoxy)-N-(3-dimethylaminopropyl)acetamide dimethanesulfonate, having prolonged pharmacodynamic half-life on mucosal surfaces, used for the treatment of cardiovascular disorders |
| 03/19/2009 | US20090076073 Therapeutic amides |
| 03/19/2009 | US20090076032 Derivatives of 18Beta-Glycyrrhetinic Acid |
| 03/19/2009 | US20090076031 Deuterium-enriched bortezomib |
| 03/19/2009 | US20090076030 Piperazine compounds |
| 03/19/2009 | US20090076020 Cyclopropyl Amide Derivatives 978 |
| 03/19/2009 | US20090076018 Deuterium-enriched ranolazine |
| 03/19/2009 | US20090074825 Colorants based n-halamines compositions and method of making and using |
| 03/19/2009 | US20090072718 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative |
| 03/19/2009 | US20090072716 Aromatic amine derivative and organic electroluminescent element using the same |
| 03/18/2009 | EP2036896A1 Cyclic amine compound |
| 03/18/2009 | EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/18/2009 | EP2035394A1 2-pyrazinecarboxamide derivatives |
| 03/18/2009 | EP2035380A2 Parp inhibitors |
| 03/18/2009 | EP2035004A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 03/18/2009 | EP2034993A2 Pyrazinones as cellular proliferation inhibitors |
| 03/18/2009 | EP2034832A2 Il-8 receptor antagonist |
| 03/18/2009 | CN100469770C 5-substituted-pyrazine or -pyridine glucokinase activators |
| 03/17/2009 | US7504537 osteoarthritis or rheumatoid arthritis |
| 03/17/2009 | CA2337849C Piperazinone derivatives and applications thereof |
| 03/12/2009 | WO2009030831A2 Novel photochromic materials |
| 03/12/2009 | WO2009030750A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use |
| 03/12/2009 | WO2008139235A3 Novel piperazine salts as d3/d2 antagonists |
| 03/12/2009 | US20090069344 Modulators of hcv replication |
| 03/12/2009 | US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/12/2009 | US20090069304 Mmp-13 selective inhibitor |
| 03/12/2009 | US20090069302 Chemical compounds |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/12/2009 | US20090067030 transparent electrode, polymer based on fluorinated derivative of (2,3-Di-thiophen-2-yl-thieno[3,4-b]pyrazine), and electrolyte; single absorption band |
| 03/12/2009 | US20090066231 Electroluminescent device |
| 03/12/2009 | CA2698306A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use |
| 03/11/2009 | EP2033956A1 A new class of histone deacetylase inhibitors |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | CN101384604A Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 03/11/2009 | CN101384582A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501416 Quinoxaline compounds and methods of using them |
| 03/10/2009 | US7501409 A tablet has an acid, with reduced solubility in the neutral and alkaline regions, is used for treating sexual disorders erectile dysfunction |
| 03/05/2009 | WO2009029439A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 03/05/2009 | WO2009027395A1 A new class of histone deacetylase inhibitors |
| 03/05/2009 | WO2009027249A2 Method for producing amines from sugar alcohols |
| 03/05/2009 | WO2009027248A1 Method for producing amines from glycerin |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 03/05/2009 | US20090062305 Deuterium-enriched cetirizine |
| 03/05/2009 | US20090062296 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity |
| 03/05/2009 | US20090062280 Ophthalmic Compositions for Treating Ocular Hypertension |
| 03/05/2009 | US20090061528 mono- and bis-substituted 8-hydroxypyrene-1,3,6-trisulfonic acid dyes (HPTA) containing pyrene rings; hydrogels; glucose sensors |
| 03/05/2009 | CA2694911A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 03/04/2009 | EP2029553A1 Substituted pyrazinone derivatives for use as a medicine |
| 03/04/2009 | EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1380306B1 Remedies for restless leg syndrome |
| 03/04/2009 | CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 03/04/2009 | CN100465173C A selective kinase inhibitor |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498330 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 02/26/2009 | WO2009024550A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 02/26/2009 | US20090054630 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2009 | US20090054460 Piperazine derivatives and methods of use |
| 02/26/2009 | US20090054453 Novel Tetralins as 5-HT6 Modulators |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054447 2,3 Substituted Pyrazine Sulfonamides as Inhibitors of CRTH2 |
| 02/26/2009 | US20090054444 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents |
| 02/26/2009 | US20090054438 Compositions and methods for inhibiting growth and metastasis of melanoma |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054417 Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | CA2694604A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 02/25/2009 | CN101374820A Piperazine compounds with a herbicidal action |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/24/2009 | US7494999 Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/24/2009 | US7494722 Tandem OLED having an organic intermediate connector |
| 02/19/2009 | WO2009022731A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022730A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2008087514A3 Hdac inhibitors |
| 02/19/2009 | US20090048445 Method of Synthesizing Quinoxaline Derivative by Microwave Irradiation |
| 02/19/2009 | US20090048256 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |